These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15264420)

  • 1. Replacement and dialysate fluids for patients with acute renal failure treated by continuous veno-venous haemofiltration and/or haemodiafiltration.
    Davenport A
    Contrib Nephrol; 2004; 144():317-28. PubMed ID: 15264420
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M; Tiula E; Backman JT; Neuvonen PJ
    J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysate and replacement fluid composition for CRRT.
    Aucella F; Di Paolo S; Gesualdo L
    Contrib Nephrol; 2007; 156():287-96. PubMed ID: 17464138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A service evaluation comparing CVVH an CVVHD in minimising circuit failure.
    Ede J; Dale A
    Nurs Crit Care; 2017 Jan; 22(1):52-57. PubMed ID: 26871268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous haemofiltration and haemodiafiltration for acute renal failure in severely burned patients.
    Leblanc M; Thibeault Y; Quérin S
    Burns; 1997 Mar; 23(2):160-5. PubMed ID: 9177886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration.
    Egi M; Naka T; Bellomo R; Cole L; French C; Trethewy C; Wan L; Langenberg CC; Fealy N; Baldwin I
    Int J Artif Organs; 2005 Dec; 28(12):1211-8. PubMed ID: 16404696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.
    Cointault O; Kamar N; Bories P; Lavayssiere L; Angles O; Rostaing L; Genestal M; Durand D
    Nephrol Dial Transplant; 2004 Jan; 19(1):171-8. PubMed ID: 14671053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance.
    Tolwani AJ; Prendergast MB; Speer RR; Stofan BS; Wille KM
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):79-87. PubMed ID: 17699194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially available replacement solutions in patients with acute renal failure.
    Davenport A
    Int J Artif Organs; 2008 Jan; 31(1):3-5. PubMed ID: 18286449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-base balance and substitution fluid during continuous hemofiltration.
    Heering P; Ivens K; Thümer O; Braüse M; Grabensee B
    Kidney Int Suppl; 1999 Nov; (72):S37-40. PubMed ID: 10560803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing Issues in Dialysis for the Patient with AKI.
    Judd E; Tolwani A
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1538-1542. PubMed ID: 28637863
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction.
    McLean AG; Davenport A; Cox D; Sweny P
    Kidney Int; 2000 Oct; 58(4):1765-72. PubMed ID: 11012911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system.
    Lonnemann G; Floege J; Kliem V; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 2000 Aug; 15(8):1189-93. PubMed ID: 10910443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of extreme hypernatremia by continuous veno-venous hemodiafiltration].
    Giabicani M; Guitard PG; Guerrot D; Grangé S; Teule L; Dureuil B; Veber B
    Nephrol Ther; 2015 Nov; 11(6):492-5. PubMed ID: 26169976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialyzability of lamotrigine by continuous venovenous haemodiafiltration.
    Premachandra K; Priyadarshini S; Roberts D
    Clin Toxicol (Phila); 2022 Feb; 60(2):267. PubMed ID: 33945365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.